COMBACTE-CARE: A New Public-Private Funded Project to Combat Carbapenem Resisitance
combacte-care
Press Release
COMBACTE-CARE
COMBACTE-CARE is laying the groundwork for tests of new and more effective treatments for when the current available antibiotics no longer suffice.
Download press release
Related trials
Want to stay up to date?
Subscribe to our newsletter!
Share this press release
Related library items
-
combacte-care Publication
Detection and Prevalence of Carbapenem-resistant Gram-negative Bacteria Among European Laboratories Part of the COMBACTE Network: A COMBACTE LAB-Net Survey
Kostyanev T, Vilken T, Lammens C, Timbermont L, van 't Veen A, Goossens H. Detection and Prevalence of Carbapenem-resistant Gram-negative Bacteria Among European Laboratories Part of the COMBACTE Network: A COMBACTE LAB-Net Survey. Int J Antimicrob Agents. 2019;53(3):268-274. -
combacte-care Poster
Semi-mechanistic Pharmacokinetic/Pharmacodynamics Modeling of Aztreonam-Avibactam Combination Against Multidrug Resistant Gram(-) Organisms
Authors: Chauzy A., Torres BGS., Buyck, J., Marquizeau E., Gobin P., de Jonge BLM, Marchand S., Couet W., Grégoire N.
